Prelude Therapeutics Inc’s filing revealed that its CLO, Interim CFO, Corp Sec. Lim Bryant David acquired Company’s shares for reported $22638.0 on Dec 19 ’24. In the deal valued at $0.91 per share,25,000 shares were bought. As a result of this transaction, Lim Bryant David now holds 27,400 shares worth roughly $35620.0.
Then, Vaddi Krishna bought 100,000 shares, generating $93,210 in total proceeds. Upon buying the shares at $0.93, the CEO now owns 1,167,275 shares.
Before that, Vaddi Krishna bought 6,888 shares. Prelude Therapeutics Inc shares valued at $6,116 were divested by the CEO at a price of $0.89 per share. As a result of the transaction, Vaddi Krishna now holds 127,553 shares, worth roughly $0.17 million.
H.C. Wainwright upgraded its Prelude Therapeutics Inc [PRLD] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Barclays’s analysts, who decreased its forecast for the stock in mid June from “an Equal weight” to “an Underweight”. JMP Securities began covering PRLD with “Mkt outperform” recommendation on March 13, 2024. H.C. Wainwright revised its rating on February 20, 2024. It rated PRLD as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PRLD
On Friday, Prelude Therapeutics Inc [NASDAQ:PRLD] saw its stock jump 46.40% to $1.30. Over the last five days, the stock has gained 62.50%. Prelude Therapeutics Inc shares have fallen nearly -69.56% since the year began. Nevertheless, the stocks have fallen -67.25% over the past one year. While a 52-week high of $6.80 was reached on 08/14/24, a 52-week low of $0.80 was recorded on 12/16/24. SMA at 50 days reached $1.2289, while 200 days put it at $3.4953.
Levels Of Support And Resistance For PRLD Stock
The 24-hour chart illustrates a support level at 1.0083, which if violated will result in even more drops to 0.7165. On the upside, there is a resistance level at 1.5209. A further resistance level may holdings at 1.7417. The Relative Strength Index (RSI) on the 14-day chart is 63.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0797, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 22.96%. Stochastics %K at 45.80% indicates the stock is a holding.
How much short interest is there in Prelude Therapeutics Inc?
A steep rise in short interest was recorded in Prelude Therapeutics Inc stocks on 2024-11-29, growing by 0.11 million shares to a total of 3.06 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 2.94 million shares. There was a rise of 3.69%, which implies that there is a positive sentiment for the stock.
